Skip to main content
. 2023 May 15;24(10):8753. doi: 10.3390/ijms24108753

Figure 5.

Figure 5

TAT-AT7 inhibited the VEGFR-2 downstream signaling pathway. The expression levels of VEGFR-2 and p-VEGFR-2 (A), PLC-γ and p-PLC-γ (B), ERK1/2 and p-ERK1/2 (C), FAK and p-FAK (D), SRC and p-SRC (E), and AKT and p-AKT (F) in HUVECs treated with AT7, TAT, TAT+AT7, and TAT-AT7 in the presence of VEGF-A165 (30 ng/mL), determined by Western blot. n = 3.